SpringerLink
Log in

Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement develo** after low-dose methotrexate therapy for rheumatoid arthritis

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Struski S, Lagarde S, Bories P, Puiseux C, Prade N, Cuccuini W, Pages MP, Bidet A, Gervais C, Lafage-Pochitaloff M, Roche-Lestienne C, Barin C, Penther D, Nadal N, Radford-Weiss I, Collonge-Rame MA, Gaillard B, Mugneret F, Lefebvre C, Bart-Delabesse E, Petit A, Leverger G, Broccardo C, Luquet I, Pasquet M, Delabesse E (2017) NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Leukemia 31(3):565–572. https://doi.org/10.1038/leu.2016.267

    Article  PubMed  CAS  Google Scholar 

  2. Gervais C, Mauvieux L, Perrusson N, Helias C, Struski S, Leymarie V, Lioure B, Lessard M (2005) A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia. Leukemia 19(1):145–148. https://doi.org/10.1038/sj.leu.2403565

    Article  PubMed  CAS  Google Scholar 

  3. Romana SP, Radford-Weiss I, Ben Abdelali R, Schluth C, Petit A, Dastugue N, Talmant P, Bilhou-Nabera C, Mugneret F, Lafage-Pochitaloff M, Mozziconacci MJ, Andrieu J, Lai JL, Terre C, Rack K, Cornillet-Lefebvre P, Luquet I, Nadal N, Nguyen-Khac F, Perot C, Van den Akker J, Fert-Ferrer S, Cabrol C, Charrin C, Tigaud I, Poirel H, Vekemans M, Bernard OA, Berger R, Groupe Francophone de Cytogenetique H (2006) NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia 20(4):696–706. https://doi.org/10.1038/sj.leu.2404130

    Article  PubMed  CAS  Google Scholar 

  4. Pointud P, Prudat M, Peron JM (1993) Acute leukemia after low dose methotrexate therapy in a patient with rheumatoid arthritis. J Rheumatol 20(7):1215–1216

    PubMed  CAS  Google Scholar 

  5. Tanaka K, Oshikawa G, Akiyama H, Ishida S, Nagao T, Yamamoto M, Miura O (2017) Acute myeloid leukemia with t(3;21)(q26.2;q22) develo** following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report. Oncol Lett 14(1):97–102. https://doi.org/10.3892/ol.2017.6151

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Pratcorona M, Abbas S, Kuipers JE, van Galen JF, Beverloo HB, Sonneveld E, Kaspers GJ, Trka J, Baruchel A, Zimmermann M, Creutzig U, Reinhardt D, Pieters R, Valk PJ, Zwaan CM (2011) NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 118(13):3645–3656. https://doi.org/10.1182/blood-2011-04-346643

    Article  PubMed  CAS  Google Scholar 

  7. Ostronoff F, Othus M, Gerbing RB, Loken MR, Raimondi SC, Hirsch BA, Lange BJ, Petersdorf S, Radich J, Appelbaum FR, Gamis AS, Alonzo TA, Meshinchi S (2014) NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report. Blood 124(15):2400–2407. https://doi.org/10.1182/blood-2014-04-570929

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Reader JC, Meekins JS, Gojo I, Ning Y (2007) A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia. Leukemia 21(4):842–844. https://doi.org/10.1038/sj.leu.2404579

    Article  PubMed  CAS  Google Scholar 

  9. de Rooij JD, Hollink IH, Arentsen-Peters ST, van Galen JF, Berna Beverloo H, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Zimmermann M, Alonzo TA, Pieters R, Meshinchi S, van den Heuvel-Eibrink MM, Zwaan CM (2013) NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia 27(12):2280–2288. https://doi.org/10.1038/leu.2013.87

    Article  PubMed  CAS  Google Scholar 

Download references

Funding

This work was supported by grants from the Project for Cancer Research and Therapeutic Evolution (P-CREATE) (19cm0106235h0002) and the Acceleration Program for Intractable Diseases Research utilizing Disease-specific iPS cells (19bm0804004h0003) of the Japan Agency for Medical Research and Development.

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan

    Kazuhisa Chonabayashi, Toshio Kitawaki, Momoko Nakamura, Shinichiro Oshima, Masakatsu Hishizawa, Kouhei Yamashita & Akifumi Takaori-Kondo

  2. Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan

    Kazuhisa Chonabayashi & Yoshinori Yoshida

  3. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Yasuhito Nannya & Seishi Ogawa

Authors
  1. Kazuhisa Chonabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshinori Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshio Kitawaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasuhito Nannya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Momoko Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinichiro Oshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masakatsu Hishizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kouhei Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Seishi Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Akifumi Takaori-Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhisa Chonabayashi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from the patient included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chonabayashi, K., Yoshida, Y., Kitawaki, T. et al. Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement develo** after low-dose methotrexate therapy for rheumatoid arthritis. Ann Hematol 98, 2841–2843 (2019). https://doi.org/10.1007/s00277-019-03838-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03838-0

Search

Navigation